The neurobiological foundation of effective repetitive transcranial magnetic brain stimulation in Alzheimer's disease
PMCID: PMC12175030
PMID: 40530618
DOI: 10.1002/alz.70337
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Publication Date: 2025-6-18
Authors: Antonioni A, Martorana A, Santarnecchi E, Hampel H, Koch G
Key Points
- rTMS demonstrates comprehensive neurobiological modulation in AD, targeting synaptic, molecular, and inflammatory pathways
- Preclinical studies showed cognitive improvements and reduced amyloid deposition across multiple AD animal models
- Emerging evidence supports rTMS as a promising precision medicine approach for personalized AD intervention
Summary
This comprehensive review explores the neurobiological mechanisms of repetitive transcranial magnetic stimulation (rTMS) in Alzheimer's disease (AD), revealing profound potential for precision medicine interventions. By systematically analyzing preclinical evidence from animal models, the study demonstrates that rTMS exerts multifaceted therapeutic effects across neurobiological domains, including synaptic plasticity, neurotransmitter modulation, and neuroinflammation reduction.
The research highlights rTMS's ability to counteract key AD pathophysiological processes by targeting multiple mechanisms: enhancing neurotrophic factor expression, reducing amyloid and tau accumulation, mitigating neuroinflammation, and restoring excitation/inhibition neural balance. Critically, animal model studies showed significant improvements in cognitive outcomes, behavioral performance, and neurobiological markers, suggesting rTMS could potentially slow disease progression from early, asymptomatic stages.